Evidence map›Paper›PMID 31917825›Full record

ArticlePLoS computational biology2020

Adaptive landscape flattening allows the design of both enzyme: Substrate binding and catalytic power.

Vaitea Opuu, Giuliano Nigro, Thomas Gaillard, Emmanuelle Schmitt, Yves Mechulam, Thomas Simonson

Abstract read
In one paragraph

Article in PLoS computational biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Transition State-Based Computational Enzyme Design.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vaitea OpuuLaboratoire de Biochimie (CNRS UMR7654), Ecole Polytechnique, Palaiseau, France.
Giuliano NigroLaboratoire de Biochimie (CNRS UMR7654), Ecole Polytechnique, Palaiseau, France.ORCID 0000-0003-3458-9952
Thomas GaillardLaboratoire de Biochimie (CNRS UMR7654), Ecole Polytechnique, Palaiseau, France.ORCID 0000-0002-5224-546X
Emmanuelle SchmittLaboratoire de Biochimie (CNRS UMR7654), Ecole Polytechnique, Palaiseau, France.
Yves MechulamLaboratoire de Biochimie (CNRS UMR7654), Ecole Polytechnique, Palaiseau, France.ORCID 0000-0003-3586-3554
Thomas SimonsonLaboratoire de Biochimie (CNRS UMR7654), Ecole Polytechnique, Palaiseau, France.ORCID 0000-0002-5117-7338

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Designed enzymes are of fundamental and technological interest. Experimental directed evolution still has significant limitations, and computational approaches are a complementary route. A designed enzyme should satisfy multiple criteria: stability, substrate binding, transition state binding. Such multi-objective design is computationally challenging. Two recent studies used adaptive importance sampling Monte Carlo to redesign proteins for ligand binding. By first flattening the energy landscape of the apo protein, they obtained positive design for the bound state and negative design for the unbound. We have now extended the method to design an enzyme for specific transition state binding, i.e., for its catalytic power. We considered methionyl-tRNA synthetase (MetRS), which attaches methionine (Met) to its cognate tRNA, establishing codon identity. Previously, MetRS and other synthetases have been redesigned by experimental directed evolution to accept noncanonical amino acids as substrates, leading to genetic code expansion. Here, we have redesigned MetRS computationally to bind several ligands: the Met analog azidonorleucine, methionyl-adenylate (MetAMP), and the activated ligands that form the transition state for MetAMP production. Enzyme mutants known to have azidonorleucine activity were recovered by the design calculations, and 17 mutants predicted to bind MetAMP were characterized experimentally and all found to be active. Mutants predicted to have low activation free energies for MetAMP production were found to be active and the predicted reaction rates agreed well with the experimental values. We suggest the present method should become the paradigm for computational enzyme design.

Indexed as

EnzymesMonte Carlo MethodAdenosine MonophosphateAzidesBinding SitesCatalysisMethionineMethionine-tRNA LigaseMutationNorleucineProtein BindingProtein EngineeringSubstrate SpecificityAdenosine MonophosphateAzidesazidonorleucineEnzymesMethionineMethionine-tRNA Ligasemethioninyl adenylateNorleucine

Identifiers

PMID31917825
PMCPMC7041857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.